TCM Life Sciences Exports 320,000 COVID-19 Test Kits... "Accelerating Global Supply"

[Asia Economy Reporter Hyunseok Yoo] Molecular diagnostics specialist TCM Life Science announced on the 23rd that it will export novel coronavirus disease (COVID-19) diagnostic kits to Vietnam, Thailand, and other countries.

The total volume of kits supplied by TCM Life Science amounts to enough for 320,000 people. It is also known that additional export discussions are underway with the United States, France, Saudi Arabia, and Central and South American countries. A TCM Life Science official stated, “Overseas inquiries about COVID-19 diagnostic kits have flooded in since the early stages of development,” adding, “Since receiving export approval for the COVID-19 diagnostic kits from the Ministry of Food and Drug Safety on the 9th, contracts have been proceeding sequentially.”

TCM Life Science’s diagnostic kit, ‘TCM-Q CoronaⅢ,’ is a product based on gene amplification (RT-PCR) technology according to the World Health Organization (WHO) recommended guidelines. It can diagnose COVID-19 infection within about one hour after ribonucleic acid (RNA) extraction. Clinical trials conducted with major domestic clinical contract organizations showed that this kit demonstrated excellent performance with both sensitivity and specificity at 99.9%.

The company stated, “Methods such as blood diagnostics take less time but have the disadvantage of lower accuracy,” and added, “Demand for our highly accurate product continues to increase to avoid cases where a negative result in the primary screening test is later confirmed positive.” They further emphasized, “We will strive to ensure smooth production and supply of the diagnostic kits without disruption,” and “We will accelerate global supply focusing on Asian and Central and South American countries where infections are rapidly spreading.”

This content was produced with the assistance of AI translation services.